Mr. Benjamin’s career began at Monsanto’s healthcare and petrochemical businesses, including a period as director of corporate venture capital. He later joined Advent Venture Partners, serving as a general partner until his retirement. After retirement, he continued his involvement with Advent as an advisor to the Life Sciences team.
Mr. Benjamin served as a non-executive director of a number of companies, including 18 years on the board of Orthofix International, most recently as chairman of the audit committee.
Read the company news release about Mr. Jerry Benjamin.
Read other coverage about Orthofix:
– Orthofix Signs Agreement With Novation for Cold Therapy Products
– Orthofix Releases Spinal Deformity Correction Product
– Orthofix Reports Net Sales of $143.8M in 4Q 2010
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
